Memic builds the Hominis robotic-assisted surgical system, designed so surgeons control robotic arms from a central console and the instruments replicate surgeons’ arm motions. The Hominis has FDA marketing authorization for single-site, natural-orifice laparoscopic-assisted transvaginal benign surgical procedures, including benign hysterectomy. The device does not perform surgery autonomously; surgeons remain in control. Memic closed a $96M Series D and plans to use the proceeds to commercialize the platform in the U.S. and expand marketing and sales outside the U.S. According to Crunchbase the company previously raised a total of $31.8M, including about $12.5M raised through OurCrowd. The company is exploring additional procedures where a system like Hominis could be beneficial as it ramps commercialization.

Total raised

$96M

Funding rounds

1

Latest round

Series D

Latest activity

Apr 2021